Inspire Medical Systems Raises FY2026 Adj EPS Guidance from $0.75-$1.25 to $1.05-$1.45 vs $0.38 Est; Raises FY2026 Sales Guidance from $825.
Inspire Medical Systems (NYSE: INSP ) raises FY2026 Adj EPS guidance from $0.75-$1.25 to $1.05-$1.45 vs $0.38 analyst estimate. Raises FY2026 sales outlook from $825.000 million-$875.000 million to $835.000 million-$875.000 million vs $843.387 million estimate.
Story updates
08:03:50 PM UTC
SquawkNews
Inspire Medical Systems (NYSE: INSP ) lowers FY2026 GAAP EPS guidance from $0.07-$0.62 to $(0.42)-$0.17 vs $0.90 analyst estimate..
Inspire Medical Systems (NYSE: INSP ) raises FY2026 Adj EPS guidance from $0.75-$1.25 to $1.05-$1.45 vs $0.38 analyst estimate.
Raises FY2026 sales outlook from $825.000 million-$875.000 million to $835.000 million-$875.000 million vs $843.387 million estimate.